MELISSA CARTER: Open Payments
NPI 1629508767 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 66 payments from 20 companies in 2025. Trend: 2023 $1,234 · 2024 $1,531 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $429 |
| Novo Nordisk Inc | 4 | $99 |
| GlaxoSmithKline, LLC. | 6 | $91 |
| Viatris Specialty LLC | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lilly USA, LLC | 3 | $61 |
| SHIELD THERAPEUTICS INC | 2 | $53 |
| Renalytix AI, Inc. | 3 | $52 |
| Amgen Inc. | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: VRAYLAR, Wegovy, UBRELVY, YUPELRI, TRELEGY ELLIPTA, MOUNJARO, ACCRUFER, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across NY — which companies pay providers there.
